Seamlessly scale from early R&D
to commercial biomanufacturing
The science of the future, a new paradigm for data
From lab-grown meat to human T-cell therapies, synthetic biology—aka synbio—companies have crossed scientific boundaries, married interdisciplinary specialties, and delivered innovations so cutting-edge they can seem like science fiction.
Far from being focused on just one field of science, synbio labs are complex. They incorporate processes, equipment, software, and scientific know-how from across industries and specialties. Complex labs though, generate complex data, and complex data needs to be managed intelligently.
Synbio companies need a specialized data infrastructure solution that enables them to automate as much as possible, grow seamlessly, and maintain a high level of manufacturing control and quality.
Need to adapt and grow quicklyWhile synbio companies start early-stage R&D with just a few instruments—like plate readers and small bioreactors—they often need to grow their data generation and processing capabilities quickly. This jump in size can be challenging and painful.
Unique path to commercializationSynbio companies may look like traditional labs at the R&D stage, but eventually growing into commercial manufacturing resembling non-life sciences companies. They need a specialized yet flexible data infrastructure solution that enables them to automate as much as possible, adapt and grow with them, and eventually maintain a high level of manufacturing control and quality.
Work with complex, edited, living cellsEmerging biotechnologies like CRISPR and gene circuits are powerful tools, but are not without their challenges. Trying to use them on living cells while keeping them alive and functional, from R&D through manufacturing, puts additional demands on the data and metadata.
Lack of existing solutionsSynbio companies aren’t fully served by most existing therapeutics-focused digital solutions. The only available solutions are usually bioinformatics-focused platforms, which are too narrowly focused to integrate anything outside of next-generation sequencing (NGS) data.
Your lab on Ganymede - Bioreactors
Ganymede provides synbio companies the right data infrastructure to handle all of the mountains of data streaming in, maintain quality, and ensure regulatory compliance. From the earliest days of discovery to global manufacturing, Ganymede grows with you.
We specialize in helping synbio companies optimize their most crucial instrument: bioreactors. These powerhouse pieces of equipment are what enable synbio companies to create their actual products. Without bioreactors, there’s no synbio. And when they’re not managed well—especially as a company grows—they can cause massive downstream problems.
Once a company has established their processes and product, it’s primetime: moving the organization into biomanufacturing.
Growing cells in bulk, however, means adding many more bioreactors, often at much larger volumes—and larger costs of failure—in as little as a few months. Successfully jumping from one machine to dozens can easily go very wrong. For example, because this process is often manual:
With Ganymede, all your bioreactor data is automatically ingested and stored in a single, easy-to-access cloud layer. Once we create one integration for one bioreactor, it’s easy to scale up rapidly,no matter how many machines you add—we’ve made adding equipment repeatable.
When Ganymede is powering your lab data infrastructure:
Learn about Ganymede and start speeding up your science.